| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.22 | 6e-12 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.21 | 3e-11 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-09 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-09 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-09 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.17 | 1e-08 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-08 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.25 | 2e-08 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-08 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-08 |